发明名称 Use Of Genetic Polymorphisms To Predict Drug-Induced Hepatotoxicity
摘要 IL1A or a gene located near IL1A on chromosome 2q14 may contribute to hepatotoxicity, as measured by increased serum levels of aspartate transaminase, during N-benzoyl-staurosporine treatment for macular edema. Accordingly, genetic polymorphisms in the IL1A gene are useful as biomarkers for predicting staurosporine derivative-mediated hepatotoxicity.
申请公布号 US2007248955(A1) 申请公布日期 2007.10.25
申请号 US20040574768 申请日期 2004.10.05
申请人 NOVARTIS AG 发明人 MCCULLOUGH KAREN;WOLFGANG CURT D.
分类号 A61K31/35;C12Q1/68 主分类号 A61K31/35
代理机构 代理人
主权项
地址